Log In
Print this Print this

ETX0914 (formerly AZD0914)

  Manage Alerts
Collapse Summary General Information
Company Entasis Therapeutics Inc.
DescriptionBenzisoxazole DNA gyrase and topoisomerase IV inhibitor against Neisseria gonorrhoeae
Molecular Target DNA gyrase ; Topoisomerase IV
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationSexually transmitted disease (STD)
Indication DetailsTreat uncomplicated urogenital gonorrhea
Regulatory Designation U.S. - Fast Track (Treat uncomplicated urogenital gonorrhea);
U.S. - Qualified Infectious Disease Program (Treat uncomplicated urogenital gonorrhea)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today